Growth factor–induced shedding of syndecan-1 confers glypican-1 dependence on mitogenic responses of cancer cells

por Ding, Kan, Lopez-Burks, Martha, Sánchez-Duran, José Antonio, Korc, Murray, Lander, Arthur D.
Publicado 2005

Nipbl and Mediator Cooperatively Regulate Gene Expression to Control Limb Development

por Muto, Akihiko, Ikeda, Shingo, Lopez-Burks, Martha E., Kikuchi, Yutaka, Calof, Anne L., Lander, Arthur D., Schilling, Thomas F.
Publicado 2014

Conditional Creation and Rescue of Nipbl-Deficiency in Mice Reveals Multiple Determinants of Risk for Congenital Heart Defects

por Santos, Rosaysela, Kawauchi, Shimako, Jacobs, Russell E., Lopez-Burks, Martha E., Choi, Hojae, Wikenheiser, Jamie, Hallgrimsson, Benedikt, Jamniczky, Heather A., Fraser, Scott E., Lander, Arthur D., Calof, Anne L.
Publicado 2016

Multiple Organ System Defects and Transcriptional Dysregulation in the Nipbl (+/−) Mouse, a Model of Cornelia de Lange Syndrome

por Kawauchi, Shimako, Calof, Anne L., Santos, Rosaysela, Lopez-Burks, Martha E., Young, Clint M., Hoang, Michelle P., Chua, Abigail, Lao, Taotao, Lechner, Mark S., Daniel, Jeremy A., Nussenzweig, Andre, Kitzes, Leonard, Yokomori, Kyoko, Hallgrimsson, Benedikt, Lander, Arthur D.
Publicado 2009

NTR 2.0: a rationally-engineered prodrug converting enzyme with substantially enhanced efficacy for targeted cell ablation

por Sharrock, Abigail V., Mulligan, Timothy S., Hall, Kelsi R., Williams, Elsie M., White, David T., Zhang, Liyun, Emmerich, Kevin, Matthews, Frazer, Nimmagadda, Saumya, Washington, Selena, Le, Katherine D., Meir-Levi, Danielle, Cox, Olivia L., Saxena, Meera T., Calof, Anne L., Lopez-Burks, Martha E., Lander, Arthur D., Ding, Ding, Ji, Hongkai, Ackerley, David F., Mumm, Jeff S.
Publicado 2022